| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |